AMA Update

AMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.

AMA CXO Todd Unger talks with Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and chair-elect of the AMA Board of Trustees about updated vaccine recommendations based on an increased, but still rare, risk of thrombosis with thrombocytopenia with the Johnson & Johnson vaccine. Also, covering the latest on Omicron and vaccine effectiveness, a vaccine safety update for children aged 5-11 and the status of a COVID vaccine for toddlers.

AMA CXO Todd Unger discusses the complex issue of vaccine mandates with three health system leaders: Robert Hart, MD, Chief Medical Officer, Ochsner Health; Adnan Munkarah, MD, Executive Vice President and Chief Clinical Officer, Henry Ford Health System; and Michael Anderson, MD, Chief Medical Officer, Virginia Mason Franciscan Health in this special COVID Update feature.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering an increase in COVID cases as the U.S. surpassed 50 million on Monday, new data from a major study released by South Africa’s largest health insurer on vaccine efficacy against Omicron, and an update on Pfizer's COVID pill.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of Omicron across the U.S. and globally, as well as New York City's vaccine mandate for private employees.

AMA CXO Todd Unger discusses the new omicron variant and what it means for the months ahead with good friend of the show, Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck's COVID pill.

AMA CXO Todd Unger talks with Paul Offit, MD, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, about pediatric COVID vaccination, mandates and boosters.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.

AMA CXO Todd Unger talks with Bechara Choucair, MD, vaccinations coordinator on the White House COVID-19 Response Team in Washington, D.C., about the nation’s vaccination strategy, including vaccine requirements, pediatric vaccination and boosters.